PARAGANGLIOMA
Clinical trials for PARAGANGLIOMA explained in plain language.
Never miss a new study
Get alerted when new PARAGANGLIOMA trials appear
Sign up with your email to follow new studies for PARAGANGLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists re-engineer Patients' own cells to hunt advanced cancers
Disease control Recruiting nowThis early-phase study is testing a new type of cell therapy for people with advanced solid tumors, including melanoma, that have spread and are not responding to standard treatments. Doctors take a patient's own immune cells, modify them in a lab to better recognize and attack c…
Matched conditions: PARAGANGLIOMA
Phase: PHASE1 • Sponsor: Anusha Kalbasi • Aim: Disease control
Last updated Apr 01, 2026 18:25 UTC
-
Radioactive drug trial offers hope for rare, untreatable tumors
Disease control Recruiting nowThis study is testing an experimental radioactive drug called Lu-177-DOTATATE for adults with rare adrenal or nerve-related tumors that cannot be removed by surgery. The main goals are to see if the treatment is safe and if it can help patients live longer without their cancer ge…
Matched conditions: PARAGANGLIOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Breakthrough radiation therapy targets Hard-to-Treat cancers with pinpoint precision
Disease control Recruiting nowThis study is testing a new targeted radiation treatment for adults with advanced neuroendocrine tumors that cannot be surgically removed or have spread. The treatment uses a radioactive substance that seeks out and delivers powerful radiation directly to cancer cells while tryin…
Matched conditions: PARAGANGLIOMA
Phase: PHASE1, PHASE2 • Sponsor: Perspective Therapeutics • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New scan aims to spot returning brain tumors more clearly
Diagnosis Recruiting nowThis study is testing whether a new type of combined PET/MRI scan can help doctors better see if certain brain tumors have come back after treatment. It will involve 200 adults who have had surgery for specific brain tumors, like meningioma. The main goal is to see if this new sc…
Matched conditions: PARAGANGLIOMA
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Diagnosis
Last updated Mar 30, 2026 14:29 UTC
-
New scans aim to pinpoint hidden tumors
Diagnosis Recruiting nowThis study is testing new types of imaging scans to better find and map rare nerve and adrenal tumors (neuroblastoma and pheochromocytoma/paraganglioma). Researchers will give participants special tracer injections and use PET or SPECT scans to see if these new methods can spot t…
Matched conditions: PARAGANGLIOMA
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Diagnosis
Last updated Mar 27, 2026 12:40 UTC
-
Scientists hunt for hidden genes in rare, inherited tumors
Knowledge-focused Recruiting nowThis study aims to find new genes linked to rare tumors called pheochromocytomas and paragangliomas, which often run in families. Researchers will analyze genetic and health information from 2,000 participants who have these tumors or related conditions. The goal is to better und…
Matched conditions: PARAGANGLIOMA
Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:19 UTC
-
Scientists test new scan to see inside rare tumors
Knowledge-focused Recruiting nowThis study is testing a new type of PET scan to see if it can better show certain rare tumors called pheochromocytomas and paragangliomas. Up to 30 adults with these tumors will get the scan before their planned surgery or drug treatment. The goal is to learn more about the tumor…
Matched conditions: PARAGANGLIOMA
Phase: EARLY_PHASE1 • Sponsor: Heather Wachtel • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC
-
Hospital launches major effort to map the mysteries of rare diseases
Knowledge-focused Recruiting nowThis study aims to create a single, large registry to collect information on many different rare diseases. It will enroll about 380 patients already being treated at the Hospital Italiano de Buenos Aires who have one of the listed rare conditions. The goal is to gather data to be…
Matched conditions: PARAGANGLIOMA
Sponsor: Hospital Italiano de Buenos Aires • Aim: Knowledge-focused
Last updated Mar 10, 2026 12:53 UTC